ubenimex has been researched along with Cancer of Cervix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kajiyama, H; Kikkawa, F; Nawa, A; Shibata, K; Terauchi, M; Tsukamoto, H | 1 |
| Fujii, H; Nakajima, M; Ueda, M; Ueki, M; Yoshizawa, K | 1 |
2 other study(ies) available for ubenimex and Cancer of Cervix
| Article | Year |
|---|---|
Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
Topics: Animals; CD13 Antigens; Disease Progression; Female; HeLa Cells; Humans; In Situ Nick-End Labeling; Leucine; Mice; Mice, Nude; Neoplasm Transplantation; Protease Inhibitors; Radiation Tolerance; Radiotherapy; Uterine Cervical Neoplasms | 2008 |
Inhibitory effects of ubenimex (bestatin) on the invasion of uterine cervical carcinoma cells and their production and activation of gelatinase A.
Topics: Aminopeptidases; Antibiotics, Antineoplastic; Cell Division; Cell Movement; Female; Gelatinases; Humans; Leucine; Matrix Metalloproteinase 2; Metalloendopeptidases; Neoplasm Invasiveness; Protease Inhibitors; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1997 |